NPHC vs NTRR: stock comparison and AI forecast
Nutra Pharma Corp (NPHC) and Neutra Corp. (NTRR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NPHC Nutra Pharma Corp
- Market Cap
- $720K
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NTRR Neutra Corp.
- Market Cap
- n/a
- P/E Ratio
- –
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NPHC turns 226.6% of its revenue into net income, against -1984.6% for NTRR.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NPHC | NTRR |
|---|---|---|
| Market Cap | $720K | – |
| EPS | $0.00 | – |
Profitability & Margins
| Metric | NPHC | NTRR |
|---|---|---|
| ROA | 37.8% | -942.0% |
| ROIC | 6.0% | – |
| Operating Margin | -1219.7% | -2046.9% |
| Net Margin | 226.6% | -1984.6% |
| EBT Margin | 4323.5% | -2066.3% |
Financial Health
| Metric | NPHC | NTRR |
|---|---|---|
| Current Ratio | 0.02x | – |
| Quick Ratio | 0.02x | – |
| Interest Coverage | -63.2x | -23.4x |
| Working Capital | -$21M | – |
Cash Flow
| Metric | NPHC | NTRR |
|---|---|---|
| Operating Cash Flow | -$1M | -$30K |
Operational Efficiency
| Metric | NPHC | NTRR |
|---|---|---|
| Inventory Turnover | 6.2x | – |
| Days Inventory | 59 days | – |
| Payables Period | 2232 days | – |
Income Statement
| Metric | NPHC | NTRR |
|---|---|---|
| Operating Income | -$1M | -$260K |
| Net Income | $240K | -$250K |
| SG&A Expense | $2M | – |
| Cost of Goods Sold | $150K | $20K |
Dividend & Shareholder Information
| Metric | NPHC | NTRR |
|---|---|---|
| Shares Outstanding | 7160M | – |
NPHC vs NTRR: stock comparison and AI forecast
Which one does Intratio's AI model rank higher, NPHC or NTRR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.